[Chen, Hong-Fei; Yang, Ze-Hua; Gao, Cong-Xi; Wu, Ting-Juan; Peng, Ya-Ling; Liu, Qian-Wen; Tang, Cai-Hong; Hu, Yue; Liu, Mei-Ling; Zheng, Xing] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hunan Prov Key Lab Tumor Microenvironm Respons Dr, Grp Lead Compound,Dept Pharm,Hengyang Med Sch, Hengyang 421001, Peoples R China.

[Gao, Cong-Xi] Kunming Med Univ, Sch Pharm, Kunming 650500, Yunnan, Peoples R China.

[Gao, Cong-Xi] Kunming Med Univ, Yunnan Key Lab Nat Med Pharmacol, Kunming 650500, Yunnan, Peoples R China.

[Ze-Hua Yang; Xing Zheng] G

Group of Lead Compound, Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medicinal School, University of South China, Hengyang421001, China<&wdkj&>Group of Lead Compound, Department of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medicinal School, University of South China, Hengyang421001, China

Oleanolic acid derivatives;A ring modification;anticancer activity;C-28 site modification;mechanism of action

药学与生物科学学院